sulfasalazine has been researched along with Albinism, Oculocutaneous in 1 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Albinism, Oculocutaneous: Heterogeneous group of autosomal recessive disorders comprising at least four recognized types, all having in common varying degrees of hypopigmentation of the skin, hair, and eyes. The two most common are the tyrosinase-positive and tyrosinase-negative types.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mahadeo, R | 1 |
| Markowitz, J | 1 |
| Fisher, S | 1 |
| Daum, F | 1 |
1 other study available for sulfasalazine and Albinism, Oculocutaneous
| Article | Year |
|---|---|
Hermansky-Pudlak syndrome with granulomatous colitis in children.
Topics: Adrenal Cortex Hormones; Albinism, Oculocutaneous; Child; Child, Preschool; Crohn Disease; Female; H | 1991 |